Typhoid Vi Polysaccharide Vaccine

BIOLOGICAL3 trials

Sponsors

Novartis, University of California, San Francisco

Conditions

HealthyJapanese EncephalitisMeningococcal DiseaseMeningococcal MeningitisPosttraumatic Stress DisorderRabiesTyphoidYellow Fever

Early Phase 1

Inflammation and Threat Sensitivity in PTSD

CompletedNCT03048929

University of California, San FranciscoPosttraumatic Stress Disorder

Start: 2019-04-01End: 2021-03-31Updated: 2021-05-13

Cognitive, Emotional, and Neural Responses to Acute Inflammation

CompletedNCT03294564

University of California, San FranciscoHealthy

Start: 2018-01-01End: 2018-12-30Updated: 2019-06-25

Phase 3

A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in Adults

CompletedNCT01466387

NovartisJapanese Encephalitis, Meningococcal Disease, Meningococcal Meningitis +3

Start: 2011-11-30End: 2012-04-30Updated: 2014-03-11

Related Papers

Safety and Immunogenicity of Typhoid Fever and Yellow Fever Vaccines When Administered Concomitantly With Quadrivalent Meningococcal ACWY Glycoconjugate Vaccine in Healthy Adults

Journal of Travel Medicine2014-10-1318 citations

Co-administration of a meningococcal glycoconjugate ACWY vaccine with travel vaccines: a randomized, open-label, multi-center study.

2014-05-0917 citations